| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Cellectar Biosciences @4.68 8/ | 14,634 | 33,000 | 0.01% | ||
| 2 | AXIS CAPITAL HOLDING | 112,500 | 162,000 | 0.06% | ||
| 3 | PROVECTUS | 200,000 | 204,000 | 0.08% | ||
| 4 | Nephrogenex Inc | 50,000 | 234,000 | 0.09% | ||
| 5 | NORTHWEST BIOTHERAPEUTICS | 67,035 | 337,000 | 0.13% | ||
| 6 | GALMED PHARMACEUTICALS LTD | 65,000 | 559,000 | 0.22% | ||
| 7 | ADVAXIS INC COM NEW | 225,000 | 756,000 | 0.29% | ||
| 8 | INOVIO PHARMACEUTICALS INC | 102,088 | 1,006,000 | 0.39% | ||
| 9 | NEWLINK GENETICS CORP COM | 77,437 | 1,659,000 | 0.65% | ||
| 10 | SYNTHETIC BIOLOGICS INCORPORATED | 1,360,000 | 2,394,000 | 0.93% | ||
| 11 | BIOBLAST PHARMA LTD | 338,110 | 2,458,000 | 0.96% | ||
| 12 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 2,750,000 | 1.07% | ||
| 13 | ALCOBRA LTD | 687,000 | 10,607,000 | 4.13% | ||
| 14 | AMPIO PHARMACEUTICALS INC | 3,370,822 | 12,000,000 | 4.67% | ||
| 15 | MEDIVATION INC | 2,244,519 | 221,916,000 | 86.32% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-14-068774, filed 2014.11.14). and New Holdings filing (0001144204-14-072900, filed 2014.12.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
